Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Com Stk Usd0.01 [Di] (MXCT.LN)

Com Stk Usd0.01 [Di] (MXCT.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 310,421
  • Shares Outstanding, K 104,519
  • Annual Sales, $ 41,288 K
  • Annual Income, $ -37,923 K
  • 60-Month Beta N/A
  • Price/Sales 9.32
  • Price/Cash Flow N/A
  • Price/Book 1.68
Trade MXCT.LN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.37
  • Most Recent Earnings $-0.05 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
290.000 +1.76%
on 05/07/24
336.000 -12.17%
on 04/24/24
-38.900 (-11.65%)
since 04/05/24
3-Month
290.000 +1.76%
on 05/07/24
390.000 -24.33%
on 02/15/24
-89.900 (-23.35%)
since 02/07/24
52-Week
180.000 +63.94%
on 10/05/23
430.000 -31.37%
on 01/15/24
-87.400 (-22.85%)
since 05/05/23
Free Barchart Webinars! Live educational sessions using site features to explore today's markets.

Most Recent Stories

More News
MaxCyte Reports Second Quarter and Half-Year 2022 Financial Results Globe Newswire - Wed Aug 10, 2022

45% Year-Over-Year Core Business Revenue Growth in Second Quarter 2022 Raises 2022 Core Revenue Growth Guidance to Approximately 30% ROCKVILLE, Md.,...

MXCT : 3.91 (+3.71%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 300.100 (+1.04%)
MaxCyte to Report Second Quarter 2022 Financial Results on August 10, 2022 Globe Newswire - Fri Jul 15, 2022

GAITHERSBURG, Md., July 15, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on...

MXCT : 3.91 (+3.71%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 300.100 (+1.04%)
MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire - Fri May 13, 2022

GAITHERSBURG, Md., May 13, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on...

MXCT : 3.91 (+3.71%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 300.100 (+1.04%)
MaxCyte Reports First Quarter Financial Results Globe Newswire - Mon May 9, 2022

MaxCyte Increases 2022 Core Revenue Growth Guidance to be at least 25% and Reiterates Milestone Revenue Guidance of $4 million...

MXCT : 3.91 (+3.71%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 300.100 (+1.04%)
MaxCyte to Participate in Upcoming Investor Conferences Globe Newswire - Tue May 3, 2022

GAITHERSBURG, Md., May 03, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on...

MXCT : 3.91 (+3.71%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 300.100 (+1.04%)
MaxCyte to Report First Quarter 2022 Financial Results on May 9, 2022 Globe Newswire - Wed Apr 20, 2022

GAITHERSBURG, Md., April 20, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on...

MXCT : 3.91 (+3.71%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 300.100 (+1.04%)
MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire - Fri Apr 15, 2022

GAITHERSBURG, Md., April 15, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT, MXCN), a leading commercial cell-engineering company...

MXCT : 3.91 (+3.71%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 300.100 (+1.04%)
MaxCyte Announces Departure of CFO and Appointment of Ron Holtz as Interim CFO, Announces Preliminary First Quarter 2022 Revenue Globe Newswire - Tue Apr 12, 2022

GAITHERSBURG, Md., April 12, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on...

MXCT : 3.91 (+3.71%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 300.100 (+1.04%)
MaxCyte Reports Fourth Quarter and Full Year Financial Results Globe Newswire - Tue Mar 22, 2022

MaxCyte Provides Initial 2022 Guidance...

MXCT : 3.91 (+3.71%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 300.100 (+1.04%)
MaxCyte, Inc. Names Cenk Sumen Chief Scientific Officer Globe Newswire - Wed Mar 9, 2022

Dr. Sumen brings extensive experience in scientific and technology evaluation, process development and leadership....

MXCT : 3.91 (+3.71%)
MXCN.LN : 680.000 (unch)
MXCT.LN : 300.100 (+1.04%)
More news for this symbol

Barchart Technical Opinion

Strong sell

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 302.000
2nd Resistance Point 301.000
1st Resistance Point 299.000
Last Price 300.100
1st Support Level 296.000
2nd Support Level 295.000
3rd Support Level 293.000

See More

52-Week High 430.000
Fibonacci 61.8% 334.500
Fibonacci 50% 305.000
Last Price 300.100
Fibonacci 38.2% 275.500
52-Week Low 180.000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot